U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C5H11NO2.H2O
Molecular Weight 135.1616
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BETAINE HYDRATE

SMILES

O.C[N+](C)(C)CC([O-])=O

InChI

InChIKey=NJZRLXNBGZBREL-UHFFFAOYSA-N
InChI=1S/C5H11NO2.H2O/c1-6(2,3)4-5(7)8;/h4H2,1-3H3;1H2

HIDE SMILES / InChI

Molecular Formula HO
Molecular Weight 17.0073
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C5H12NO2
Molecular Weight 118.1543
Charge 1
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Betaine is a methyl derivative of glycine first isolated from the juice of sugar beets. Betaine is found in many common foods, but concentrated significantly in beets, spinach, wheat foods, and shellfish. In addition, betaine can be synthesized within the human body. Betaine participates in the methionine cycle, which produces vital biomolecules including proteins, hormones, phospholipids, polyamines, and nutrients. Betaine is used as a dietary supplement and has a beneficial effect on the human health. In the USA, FDA approved a betaine-containing drug Cystadane for the treatment of homocystinuria. The drug acts as a methyl group donor in the remethylation of homocysteine to methionine.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
CYSTADANE

Approved Use

Cystadane is a methylating agent indicated for the treatment of homocystinuria to decrease elevated homocysteine blood levels. Included within the category of homocystinuria are Cystathionine beta-synthase (CBS) deficiency, 5,10-methylenetetrahydrofolate reductase (MTHFR) deficiency, Cobalamin cofactor metabolism (cbl) defect.

Launch Date

8.4620162E11
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
1.456 mM
50 mg/kg bw 2 times / day multiple, oral
dose: 50 mg/kg bw
route of administration: Oral
experiment type: MULTIPLE
co-administered:
BETAINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
0.939 mM
50 mg/kg bw single, oral
dose: 50 mg/kg bw
route of administration: Oral
experiment type: SINGLE
co-administered:
BETAINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
12.528 mM × h
50 mg/kg bw 2 times / day multiple, oral
dose: 50 mg/kg bw
route of administration: Oral
experiment type: MULTIPLE
co-administered:
BETAINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
5.518 mM × h
50 mg/kg bw single, oral
dose: 50 mg/kg bw
route of administration: Oral
experiment type: SINGLE
co-administered:
BETAINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
41.17 h
50 mg/kg bw 2 times / day multiple, oral
dose: 50 mg/kg bw
route of administration: Oral
experiment type: MULTIPLE
co-administered:
BETAINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
14.38 h
50 mg/kg bw single, oral
dose: 50 mg/kg bw
route of administration: Oral
experiment type: SINGLE
co-administered:
BETAINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
Doses

Doses

DosePopulationAdverse events​
20 g 1 times / day multiple, oral
Highest studied dose
Dose: 20 g, 1 times / day
Route: oral
Route: multiple
Dose: 20 g, 1 times / day
Sources:
unhealthy, adult
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders.
1994 Aug
Cerebrospinal fluid and plasma total homocysteine and related metabolites in children with cystathionine beta-synthase deficiency: the effect of treatment.
1997 Nov
Effects of amplification facilitators on diagnostic PCR in the presence of blood, feces, and meat.
2000 Dec
Betaine and homocysteine concentrations in infant formulae and breast milk.
2001 Dec
Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study.
2001 Sep
Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects.
2002 Nov
Betaine-homocysteine S-methyltransferase-2 is an S-methylmethionine-homocysteine methyltransferase.
2008 Apr 4
Long follow up of betaine therapy in two Japanese siblings with cystathionine beta-synthase deficiency.
2008 Oct
S-Adenosylhomocysteine increases beta-amyloid formation in BV-2 microglial cells by increased expressions of beta-amyloid precursor protein and presenilin 1 and by hypomethylation of these gene promoters.
2009 Jul
Assessment of the effect of betaine on p16 and c-myc DNA methylation and mRNA expression in a chemical induced rat liver cancer model.
2009 Jul 30
Protective effect of betaine on changes in the levels of lysosomal enzyme activities in heart tissue in isoprenaline-induced myocardial infarction in Wistar rats.
2009 Nov
S-Adenosylhomocysteine enhances DNA damage through increased β-amyloid formation and inhibition of the DNA-repair enzyme OGG1b in microglial BV-2 cells.
2011 Dec 18
Effects of betaine on lipopolysaccharide-induced memory impairment in mice and the involvement of GABA transporter 2.
2011 Nov 4
Wilson's disease: changes in methionine metabolism and inflammation affect global DNA methylation in early liver disease.
2013 Feb
A urinary metabonomics study on biochemical changes in yeast-induced pyrexia rats: a new approach to elucidating the biochemical basis of the febrile response.
2013 Jun 25
Betaine supplementation protects against renal injury induced by cadmium intoxication in rats: role of oxidative stress and caspase-3.
2014 Mar
Proteomics analysis of altered cellular metabolism induced by insufficient copper level.
2014 Nov 10
The organic osmolyte betaine induces keratin 2 expression in rat epidermal keratinocytes - A genome-wide study in UVB irradiated organotypic 3D cultures.
2015 Dec 25
Regulation of signal transducer and activator of transcription 3 and apoptotic pathways by betaine attenuates isoproterenol-induced acute myocardial injury in rats.
2015 May
Patents

Sample Use Guides

The usual dosage in adult and pediatric patients is 6 grams per day administered orally in divided doses of 3 grams twice daily. In pediatric patients less than 3 years of age, dosage may be started at 100 mg/kg/day divided in twice daily doses, and then increased weekly by 50 mg/kg increments.
Route of Administration: Oral
HeLa cells were treated with 0.1, 1.0, 5.0, 20.0, 100.0 mg/ml of betaine to evaluate the anticancer efficacy of the compound. The percentage of S phase cells in the low dose groups (< 5mg/ml) were distinctly higher than in high dose groups, and the rates of Sub-G1 phase were the opposite. A high concentration of betaine (>5.0mg/ml) significantly promoted the apoptosis of HeLa cells.
Substance Class Chemical
Created
by admin
on Wed Jul 05 22:32:53 UTC 2023
Edited
by admin
on Wed Jul 05 22:32:53 UTC 2023
Record UNII
TPU0ITR2BR
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BETAINE HYDRATE
Common Name English
(CARBOXYMETHYL)TRIMETHYLAMMONIUM HYDROXIDE
Systematic Name English
BETAINE MONOHYDRATE [MI]
Common Name English
BETAINE MONOHYDRATE
MI   WHO-DD  
Common Name English
TRIMETHYLGLYCINE HYDROXIDE
Systematic Name English
Betaine monohydrate [WHO-DD]
Common Name English
Code System Code Type Description
CAS
590-47-6
Created by admin on Wed Jul 05 22:32:53 UTC 2023 , Edited by admin on Wed Jul 05 22:32:53 UTC 2023
PRIMARY
MERCK INDEX
M2451
Created by admin on Wed Jul 05 22:32:53 UTC 2023 , Edited by admin on Wed Jul 05 22:32:53 UTC 2023
PRIMARY Merck Index
PUBCHEM
83815
Created by admin on Wed Jul 05 22:32:53 UTC 2023 , Edited by admin on Wed Jul 05 22:32:53 UTC 2023
PRIMARY
FDA UNII
TPU0ITR2BR
Created by admin on Wed Jul 05 22:32:53 UTC 2023 , Edited by admin on Wed Jul 05 22:32:53 UTC 2023
PRIMARY
EVMPD
SUB13060MIG
Created by admin on Wed Jul 05 22:32:53 UTC 2023 , Edited by admin on Wed Jul 05 22:32:53 UTC 2023
PRIMARY
EPA CompTox
DTXSID7049421
Created by admin on Wed Jul 05 22:32:53 UTC 2023 , Edited by admin on Wed Jul 05 22:32:53 UTC 2023
PRIMARY
SMS_ID
100000077392
Created by admin on Wed Jul 05 22:32:53 UTC 2023 , Edited by admin on Wed Jul 05 22:32:53 UTC 2023
PRIMARY
ECHA (EC/EINECS)
209-684-7
Created by admin on Wed Jul 05 22:32:53 UTC 2023 , Edited by admin on Wed Jul 05 22:32:53 UTC 2023
PRIMARY
Related Record Type Details
ANHYDROUS->SOLVATE
PARENT -> SALT/SOLVATE